Prior Expectations
HY24
From $9.1m NZ impairment drove a $9.2m statutory loss even as EBITDA rose 9.5%
The release states the earnings result was in line with August guidance, and no quantified forward-work or formal FY24 target was supplied. Annualised HY24 revenue of NZD 260.4m sits just below FY23 revenue of NZD 263.5m, implying a broadly flat run-rate rather than a step-change — but the disclosed FY23 pattern was second-half-weighted (HY23 was 52.4% of FY23 revenue yet the full-year NPAT was a NZD 10.5m loss), so the second-half shape has historically been the more difficult half. Nothing in this release indicates that has reversed, particularly given the impairment signalling a weaker NZ outlook.